LBO — AULTMAN ORRVILLE HOSPITAL
IRR: 27.1% | MOIC: 3.31x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
27.1%
IRR
3.31x
MOIC
$19.7M
Entry EV
$42.9M
Exit EV
$10.1M
Equity Invested
Sources & Uses
S&UTotal · $19.7M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $7.6M | 38.8% | |
| Sub Debt | $1.9M | 9.7% | |
| Equity | $10.1M | 51.5% | |
| Enterprise Value | $19.1M | 97.1% | |
| Transaction Fees | $0.6M | 2.9% | |
| Total Uses | $19.7M | 100.0% |
Interpretation
INTAt 3.31x MOIC and 27.1% IRR over 5 years, this deal exceeds the typical 20% hurdle — strong candidate.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $4.1M |
| Exit Ev | $42.9M |
| Net Debt At Exit | $9.4M |
| Equity At Exit | $33.5M |
| Equity Invested | $10.1M |
| Total Value Created | $23.4M |
| Value From Growth | $22.9M |
| Value From Multiple | $1.0M |
| Value From Deleveraging | $0.1M |